Chronic Medication Polypharmacy among Children with and without Documented Obesity
Sunday, April 24, 2022
1:15 PM – 1:30 PM US MT
Location: Convention Center: Mile High Ballroom 2C
CE: Enduring CME: 0.25
Publication Number: 2550.2
Kathryn Kyler, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Matthew Hall, Children's Hospital Association, Lenexa, Kansas, KS, United States; James W. Antoon, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, United States; Jennifer Goldman, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Carlos Grijalva, Vanderbilt University Medical Center, Nashville, TN, United States; Abigail Musial, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Samir S. Shah, Journal of Hospital Medicine, Cincinnati, OH, United States; Sonya Tang Girdwood, Cincinnati Children's Hospital Medical Center, Fort Thomas, KY, United States; Derek Williams, Vanderbilt, Nashville, TN, United States; James A. Feinstein, University of Colorado, Aurora, CO, United States
Presenting Author(s)
Kathryn E. Kyler, MD, MS
Assistant Professor of Pediatrics Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States
Participants should be aware of the following financial/non-financial relationships:
Kathryn Kyler, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Matt Hall, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
James W. Antoon, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jennifer Goldman, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Carlos Grijalva, MD, MPH: ● AHRQ (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● CDC (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● FDA (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Merck (Currently Ongoing) (Products/Services: Consultant). ● NIH (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Pfizer (Ended In the Past 24 Months) (Products/Services: Consultant). ● Sanofi (Ended In the Past 24 Months) (Products/Services: Consultant). ● Syneos Health (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Abigail Musial, MD, MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Samir S. Shah, MD, MSCE, MHM: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sonya Tang Girdwood, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Derek Williams, MD, MPH: ● Biomerieux (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator).
James A. Feinstein, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
